Dienstag, 28. Februar 2017


  • Pressemitteilung BoxID 60639

Roche's xCELLigence System: First Cell Analyzer System Installed at AgenoLab in Stuttgart

(lifePR) (Penzberg, ) On April 3rd, three months before worldwide launch, Roche Applied Science sold the first xCELLigence System at the Analytica 2008 trade in Munich. In July the system has been installed at AgenoLab GmbH & Co. KG in Stuttgart (Germany), a supplier of contract biotechnology and life science laboratory services. AgenoLab is the first company worldwide using the new technology of Roche Applied Science for real-time cell monitoring. Also the company uses the latest LightCycler 480 instrument for real-time PCR analysis. AgenoLab offers worldwide services in GMP production, microbiology, molecularbiology, cell culture technology, tissue engineering, quality assurance, oncology, and histology.

The cell-based xCELLigence System was originally invented by US-based ACEA Biosciences, and co-developed by Roche and ACEA. The xCELLigence System will be marketed exclusively by Roche on a worldwide basis. The design of the electronic sensor and other innovative techniques to collect and assess data make this system an excellent platform for cell-based assays and provide a benchmark potential for cellular and molecular biology. Continuous measurement is performed label free and fast - the system needs less than 15 seconds to analyze a 96 well E Plate.

"The fact that the first xCELLigence Systems have already been ordered before the official product launch shows that there is a real need for this new technology in cell analysis," states Manfred Baier, Head of Roche Applied Science.

For more information on the technology of the xCELLigence System, please visit www.xCELLigence.roche.com .

Diese Pressemitteilungen könnten Sie auch interessieren

Die Lymphschleife

, Gesundheit & Medizin, CG LYMPHA GmbH

Sie ist Türkis mit weißen Punkten und macht Patienten mit Lipödem und Sekundärem Lymphödem Hoffnung – denn Sie sind nicht allein und können das...

Erfolg für den Initiative Chronische Wunden e. V.: Erforderliche Wundbehandlungsmittel für chronische Wunden werden weiterhin erstattet

, Gesundheit & Medizin, Initiative Chronische Wunden e.V.

Vor der Entscheidung über das neue Heil- und Hilfsmittelgesetz (HHVG) hat der ICW e.V. seine Unterschriften im Rahmen einer Petition zum HHVG...

Multiple Sklerose: Erkrankung, Diagnostik und Therapie

, Gesundheit & Medizin, AMSEL e.V., Aktion Multiple Sklerose Erkrankter, Landesverband der DMSG in Baden-Württemberg e.V.

Am Mittwoch, den 15. März, lädt AMSEL e.V. gemeinsam mit der AMSEL-Kontaktgruppe Bietigheim-Bissingen ab 18.30 Uhr zum Fachvortrag „Multiple...

Disclaimer